SGS SA delivered record fiscal 2025 results with 5.6% organic growth, matching analyst expectations, and an adjusted operating margin of 16.0%, exceeding forecasts by 30 basis points. The Swiss firm reported CHF 6.95 billion in sales, slightly above the CHF 6.93 billion consensus, driven by strong performance in its Connectivity & Products and Industries & Environment divisions. Adjusted operating income hit a CHF 1.11 billion record, with earnings per share rising 12.3% to CHF 3.48.

Health & Nutrition stood out with a 14.1% operating margin, surpassing the 12.8% analyst estimate, while free cash flow reached CHF 841 million, outpacing projections of CHF 786 million. The company completed its CHF 150 million cost-saving plan ahead of schedule and fully implemented Strategy 27, which includes acquisitions like Applied Technical Services. CEO Géraldine Picaud emphasized the strategy’s success in boosting sales, profitability, and cash generation.

For 2026, SGS guided for 5-7% organic growth plus 5-7% acquisition-driven growth, maintaining a 16%+ adjusted operating margin. Analysts note the margin target appears conservative given current momentum. The firm plans a capital markets event in late 2026 to outline its next strategic phase, signaling confidence in sustained performance amid market volatility.

SGS 2025 financial results underscore its resilience in industrial and environmental markets. With margin expansion and disciplined growth, the company positions itself for long-term stability, though investors will watch for execution risks in its ambitious 2026 guidance. The stock’s performance reflects optimism about its strategic pivot toward high-margin segments.